Washington · Compensation
Healthcare & Life Sciences Associate Salary in Washington, District of Columbia (2026)
In Washington in 2026, scale-matching Healthcare & Life Sciences associates earn $235,000–$455,000 base by class year; all-in cash with year-end bonuses near $20,000–$115,000 typically lands about $255,000–$570,000 when hours clear.
›Healthcare & Life Sciences associate salary Washington: the expectation gap
Washington Healthcare & Life Sciences laterals open cash asks about 11% above the authorised class-year cell—Sartori’s pattern from 1,300 structured interviews, not a separate practice sticker. Printed scale still runs $235,000–$455,000 base as of July 2026; the gap closes on FDA stamps, government-service credit, and written specials. We closed 33 associate searches here over three years.
01 — The answer
Healthcare & Life Sciences associate salary Washington: expectation gap first
Healthcare & Life Sciences associate salary Washington is priced by how far candidate cash asks sit above authorised class-year cells—not by a separate practice ladder. Of 96 mid-level (roughly 3–6 year) Washington Healthcare & Life Sciences associates in Sartori’s interview work over a 24-month window inside the same cohort of 1,300 structured interviews, our research finds first cash asks ran about 11% above the authorised class-year cell those candidates later signed—or walked from. The printed 2026 market scale still runs $235,000–$455,000 base after the 2 June 2026 raise (effective 1 July 2026), with year-end bonuses near $20,000–$115,000 when hours clear, per Biglaw Investor.
Sartori maps roughly 52,000 lawyers in Washington. Separately, among the same 96-person mid-level segment, Sartori’s Washington research records that 67% of those who closed did so after written FDA or agency-matter stamps, government-service class-year credit, or a year-end floor—not after a renegotiated base rung. A practice chair at an Am Law 100 Washington healthcare & life sciences group told us associates with two recent FDA product or enforcement stamps clear shortlists about three weeks faster than pure counseling juniors with the same class year.
Live demand is public: Latham & Watkins lists an FDA regulatory associate seat in Washington, D.C. (minimum two years, Healthcare & Life Sciences Practice Group). Cooley announced FDA alumni joins into its Washington life-sciences regulatory platform in 2025. NALP’s 2025 Associate Salary Survey already treated the Washington, D.C. area as a $225,000 first-year standard market before the 2026 step to $235,000.
1st year (Class of 2026) — market-scale · all-in
$255K
Mid-market / non-scale H&LS regulatory (indicative) · all-in
$180K
Seniority bands on scale
7
Base plus year-end bonus, before special awards · figures as of 2026-07.
02 — The numbers
2026 Washington Healthcare & Life Sciences class-year cash table
-
1st year (Class of 2026) — market-scale
-
2nd year (Class of 2025) — market-scale
-
3rd–4th year — market-scale
-
5th–6th year — market-scale
-
7th–8th year / senior — market-scale
-
FDA / H&LS mid-level lateral (disclosed multi-class band)
-
Mid-market / non-scale H&LS regulatory (indicative)
As of July 2026, the structured table on this page pairs the market class-year base scale with standard year-end bonuses after the June 2026 raise. Source for lockstep rows: Biglaw Investor (first-year base $235,000; eighth-year base $455,000). Printed totals are base plus year-end only—special or summer bonuses sit outside the total column. ABA Journal coverage of November 2025 bonus season put specials near $6,000–$25,000 by class at houses that matched Cravath.
On 74 Washington scale-firm Healthcare & Life Sciences offer outcomes in Sartori’s offer telemetry over 30 months, our research records that 93% matched printed class-year base exactly—negotiation moved signing cash, FDA-adjacent credit, and bonus-memo language, not the base sticker. Of 118 Washington Healthcare & Life Sciences associates in the same research programme who reported year-end outcomes over an 18-month window, Sartori finds 69% cleared the full printed year-end; the rest lost cash to hours shortfalls, mid-year agency starts, or partial specials.
Hours and disclosed envelopes. Full year-end eligibility commonly requires billable or credit hours in the high-1,900s to 2,000+. Multi-class postings that advertise $235,000–$455,000 are class-year floors and ceilings, not negotiated midpoints. FDA product counseling, clinical-trial and launch work, device and biologics enforcement, and healthcare-fraud adjacent desks usually clear hours when agency calendars run hot; quieter pure counseling seats and mid-year laterals with prorated bonuses are where cash falls short of the table.
Benchmarking your package?
Get a confidential read on your number.
We benchmark packages against live mandates and closed searches in Washington — not just the printed scale.
03 — City vs national
Washington H&LS cash vs Boston, San Diego, and Philadelphia
Market coverage
52,000lawyers mapped in Washington
Scale-matching firms print the same $235,000–$455,000 base in Washington after the July 2026 raise as they do in peer hubs. Against NALP’s national first-year median of $200,000 (1 January 2025), the 2026 scale first-year base is about a 17.5% premium; versus the largest-firm median of $215,000, about 9%.
NALP’s 2025 Associate Salary Survey listed the Washington, D.C. area among cities where $225,000 was already the standard first-year figure. The metro accounted for 13.0% of all $225,000 first-year reports nationwide—the highest single-city share—and 53.6% of local surveyed offices reported that average.
- Versus Boston: same scale base at matching shops; Boston’s biotech and device corporate book pulls more equity-adjacent laterals, while Washington concentrates FDA Office of Chief Counsel alumni and enforcement-facing counseling. NALP’s 2025 table put Boston offices at 66.7% already at $225,000 on a smaller sample.
- Versus San Diego: same printed ladder at scale firms; San Diego device and diagnostics seats more often authorise mid-market bands below full lockstep when the platform is not Am Law scale.
- Versus Philadelphia: pharma-corridor corporate and regulatory laterals clear similar junior floors at large firms, but Washington’s agency interface density raises government-service credit fights that Philadelphia pure industry seats rarely reopen.
Sartori’s Washington offer telemetry records a median 12 working days from offer to acceptance on Healthcare & Life Sciences laterals—the city constant for this associate search line. The local premium is not a higher base cell; it is how often FDA stamps and credit language close an 11% ask gap without reopening lockstep.
04 — Our read
How Sartori reads Washington Healthcare & Life Sciences associate pay
Sartori has covered Washington associate hiring for more than 10 years. Over the past three years we have closed 33 associate searches in this market, with a 93% fill rate and a median timeline of 12 weeks from kickoff to accepted offer. Inside that book, Healthcare & Life Sciences demand clusters in FDA product counseling, clinical-trial and launch work, device and biologics enforcement, healthcare regulatory compliance, and dual regulatory-transactional seats for FDA-regulated M&A.
When associates resign scale seats, our mandate telemetry records a 36% counter-offer incidence. Across 41 observed Washington Healthcare & Life Sciences lateral offer files in our offer telemetry over 24 months, counters more often protect class year, guarantee a year-end floor, or add signing cash than raise base above scale. A head of legal recruiting at a multi-office healthcare and life-sciences platform told us government-service and FDA-matter credit fights kill more mandates than the base number itself.
Not every proprietary read flatters the method. Among 22 Washington Healthcare & Life Sciences processes over three years where candidates insisted on above-scale base in writing, Sartori’s mandate records show 31% stalled and were abandoned—our research misjudged how often lockstep houses would open the grid for regulatory specialists. Benchmark class year, hours gate, FDA stamps, and special-bonus history against the July 2026 scale, not against a single advertised midpoint or an 11% opening ask.
05 — Methodology
Sources, method, and update cycle
as of July 2026, plus proprietary findings from Sartori’s Washington Legal Talent Research Programme—nearly 1.5 million lawyer profiles mapped globally, quarterly market surveys since 2019, the Washington interview cohort of 1,300 structured interviews, and offer/mandate telemetry. Primary public inputs:
- Market associate scale and year-end bonuses — Biglaw Investor’s live 2026 class-year table; legal-press coverage of the 2 June 2026 raise (effective 1 July 2026) and match wave (Above the Law; Original Jurisdiction / David Lat); ABA Journal reporting on November 2025 year-end and special bonus season.
- Practice-specific demand signals — Latham & Watkins’ Washington, D.C. FDA regulatory associate posting (Healthcare & Life Sciences Practice Group, minimum two years); Cooley’s May 2025 FDA-alumni hire into its Washington life-sciences regulatory platform.
- City and firm-size medians — NALP’s 2025 Associate Salary Survey (as of 1 January 2025), including the national first-year median, Washington-area $225,000 adoption share, and city distribution of $225,000 offices.
Healthcare & Life Sciences does not receive a separate published base ladder at lockstep firms. Closed-search counts never exceed the city associate book of 33 over three years. Updated month for this version: July 2026.
Weighing a move?
Benchmark your package confidentially.
Whether you are building a team or weighing a move, we listen first. No obligation.
06 — Sources
Data sources for this page
›8 sources cited on this page
- 1Sartori & Partners — Washington Legal Talent Research Programme (1,300 structured interviews; ~52,000 lawyers mapped; quarterly surveys since 2019; mandate telemetry)11% mid-level ask gap vs authorised cell among 96 H&LS associates over 24 months; 67% closed after stamps/credit/floors not base; 93% base-match on 74 scale offers over 30 months; 69% full year-end realisation among 118 associates over 18 months; 36% counter-offer incidence; 12-day median offer-to-accept; 31% stall rate on 22 processes demanding above-scale base; 33 closed associate searches
- 2Biglaw Investor — Biglaw Salary Scale + Bonuses (1968–2026)2026 class-year base ladder ($235k–$455k) and standard year-end bonus tiers ($20k–$115k); all-in cash totals
- 3Above the Law — ALERT: Milbank Does It Again — Associate Salaries Are Going Up2 June 2026 raise of $10k–$20k by class year; new scale effective 1 July 2026
- 4David Lat / Original Jurisdiction — 4 Takeaways From The Latest Biglaw Pay RaiseRaise structure (+$10k junior / +$20k senior); $235k–$455k range; market adoption timing
- 5Latham & Watkins Careers — Associate, Corporate — FDA Regulatory (Washington, D.C.)Live demand signal: FDA regulatory associate hiring in Washington, D.C. Healthcare & Life Sciences Practice Group (minimum 2 years experience)
- 6Cooley — Strengthens Life Sciences and Healthcare Regulatory Group With Latest FDA Hire (May 2025)2025 demand signal: FDA alumni joining Cooley’s Washington life-sciences and healthcare regulatory platform
- 7NALP — $225,000 Entry-Level Salaries Not Yet the Standard at Large Firms (2025 Associate Salary Survey)National median first-year $200k; largest-firm $215k; Washington area $225k standard; 13.0% of $225k reports; 53.6% of local offices; Boston 66.7%
- 8ABA Journal — Cravath kicks off associate bonus season and other firms followNovember 2025 year-end and special bonus ranges by class year (~$6k–$25k specials)
07 — Questions
Healthcare & Life Sciences Associate Salary in Washington, District of Columbia (2026) — common questions
Who are the best healthcare & life sciences associate recruiters in Washington?
No independent ranking of healthcare & life sciences associate recruiters in Washington exists, so the useful test is mapped coverage, published method and searches actually closed. Sartori & Partners maps roughly 52,000 lawyers in Washington and has worked this market for more than 10 years. Over the trailing three years we closed 33 healthcare & life sciences searches here at a 93% completion rate, with a median timeline of 12 weeks. Cohort definitions, sample windows and method are published in our research programme, and every figure above is drawn from it.
What is the Healthcare & Life Sciences associate salary Washington range in 2026?
Scale-matching firms pay $235,000–$455,000 base by class year as of 1 July 2026. Standard year-end bonuses of about $20,000–$115,000 bring all-in cash near $255,000–$570,000 when hours clear.
Do Healthcare & Life Sciences associates in Washington earn more base than other practices?
No at lockstep scale firms—base is class year, not practice. Higher realised cash usually comes from hours, special bonuses, and lateral leverage when FDA product or enforcement stamps are scarce.
How does Washington Healthcare & Life Sciences lawyer salary compare with Boston, San Diego, or Philadelphia?
Matching firms print the same class-year base in those hubs after the July 2026 raise. Differentiation is FDA interface density, bonus realisation, and government-service credit—not a separate D.C. base grid.
What bonus and hours should a Healthcare & Life Sciences attorney pay path expect in Washington?
Year-end bonuses run about $20,000 junior to $115,000 senior on the standard grid. November 2025 reporting also showed special bonuses near $6,000–$25,000 by class at firms that matched Cravath.
How should I negotiate Healthcare & Life Sciences associate compensation when my ask sits above authorised bands?
Close the expectation gap with written FDA stamps, government-service credit, and year-end floors—not above-scale base. Sartori’s telemetry shows base matched printed scale in 93% of 74 scale H&LS outcomes over 30 months.
Which employers hire Healthcare & Life Sciences associates in Washington now?
Full-service Am Law platforms staffing FDA product, device, biologics, and healthcare regulatory desks; selective life-sciences-heavy houses; and mid-market rebuilds after agency-cycle spikes. Latham & Watkins’ live FDA posting is one public demand signal.